WHO announces their HIV prevention recommendation

July 15, 2025

The World Health Organization (WHO) has published new HIV prevention guidelines titled “Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis.”

WHO called lenacapavir (LEN) “a transformative step forward in protecting people at risk of HIV – particularly those who face challenges with daily adherence, stigma, or access to healthcare” in an announcement. Additionally, WHO outlines their testing recommendations in the document: rapid diagnostic tests for those using long-acting injectable PrEP.

LEN is injected twice a year for the prevention of HIV. WHO hopes their decision to recommend LEN will help broaden accessibility to HIV prevention.

About the Author

Erin Brady

Managing Editor

Erin Brady is Managing Editor of Medical Laboratory Observer.

Sign up for Medical Laboratory Observer eNewsletters